NCT07794410

Brief Summary

The goal of this study is to learn how well different imaging tests detect and describe perianal fistulas in adults with Crohn's disease or fistulas with no known cause (cryptogenic). Perianal fistulas are painful tunnels that form near the anus and can lead to discharge, swelling, or infection. The main questions this study aims to answer are: How accurate is transperineal ultrasound (TPUS) compared to magnetic resonance imaging (MRI) in finding fistulas? How well do these tests identify key features like internal openings and abscesses? Do the test results help doctors make better treatment decisions? Researchers will compare TPUS and MRI to two other imaging methods: Endoscopic ultrasound (EUS), which uses a small camera and ultrasound inside the rectum Examination under anesthesia (EUA), in which a surgeon checks the area while the participant is asleep All participants will: Be adults between the ages of 18 and 75 Have a suspected or confirmed perianal fistula Be able to complete all four tests-TPUS, MRI, EUS, and EUA-within 10 days Participants will not receive any experimental treatments. The tests are part of routine care and will be done using advanced equipment by expert doctors. Each test result will be used to compare how accurate and useful the test is in real-life diagnosis and treatment planning. This study may help make fistula diagnosis faster, safer, and more affordable-especially in settings where access to MRI or surgery is limited. It may also support the use of TPUS as a first step in evaluating perianal fistulas in people with Crohn's disease.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Jul 2025Apr 2027

Study Start

First participant enrolled

July 25, 2025

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

August 3, 2025

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

August 31, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2027

Expected
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Last Updated

August 31, 2026

Status Verified

August 1, 2026

Enrollment Period

1.7 years

First QC Date

August 3, 2025

Last Update Submit

August 27, 2026

Conditions

Keywords

fistulacrohn diseasetransperineal ultrasoundmagnetic resonance imagingendoscopic ultrasoundexamination under anaesthesia

Outcome Measures

Primary Outcomes (1)

  • Per-lesion sensitivity of transperineal ultrasound (TPUS) and magnetic resonance imaging (MRI) for detecting perianal fistulas

    To determine and compare the diagnostic sensitivity of TPUS and MRI for identifying individual fistulous tracts, using endoscopic ultrasound (EUS) as the reference standard and examination under anesthesia (EUA) as the gold standard.

    Within 10 days of enrollment (all four imaging modalities completed within this window)

Secondary Outcomes (4)

  • Sensitivity of TPUS vs MRI for detecting internal openings

    Within 10 days of enrollment

  • Classification accuracy (Parks criteria) of transperineal ultrasound (TPUS) versus magnetic resonance imaging (MRI)

    Within 10 days of enrollment

  • Sensitivity of transperineal ultrasound (TPUS) vs magnetic resonance imaging (MRI) for detecting perianal abscesses

    Within 10 days of enrollment

  • Impact on clinical management based on imaging modality

    Up to 14 days after imaging

Study Arms (1)

Single Group: Quadrimodal Imaging Assessment

EXPERIMENTAL

All participants in this arm will undergo four diagnostic imaging procedures-transperineal ultrasound (TPUS), magnetic resonance imaging (MRI), endoscopic ultrasound (EUS), and examination under anesthesia (EUA)-in a predefined sequence. Each imaging modality will be used to evaluate the presence, type, and extent of perianal fistulas. This single-arm design allows within-subject comparison of diagnostic accuracy and clinical impact across modalities.

Diagnostic Test: Transperineal Ultrasound (TPUS)Diagnostic Test: Magnetic Resonance Imaging (MRI)Diagnostic Test: Endoscopic Ultrasound (EUS)Diagnostic Test: Examination Under Anesthesia (EUA)

Interventions

Participants will undergo TPUS using a high-frequency linear and microconvex probe to evaluate fistula tracts, internal openings, and abscesses.

Single Group: Quadrimodal Imaging Assessment

MRI of the pelvis will be performed using standardized T2-weighted, STIR, and post-contrast sequences for anatomical characterization of fistulas.

Single Group: Quadrimodal Imaging Assessment

EUS of the anorectal canal will be performed using a linear echoendoscope to visualize internal openings, fistula tracts, and perirectal collections. EUS serves as the reference standard.

Single Group: Quadrimodal Imaging Assessment

Participants will undergo EUA by a colorectal surgeon to probe fistula tracts and identify internal openings. EUA serves as the gold standard comparator.

Single Group: Quadrimodal Imaging Assessment

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults between 18 and 75 years of age
  • Clinical suspicion or diagnosis of perianal fistula
  • Fistula etiology can be Crohn's disease or cryptogenic/tubercular (non-Crohn's)
  • Ability to undergo all four imaging procedures (TPUS, MRI, EUS, and EUA) within a 10-day period
  • Willing and able to provide written informed consent

You may not qualify if:

  • Known or suspected anorectal malignancy
  • Pregnancy or breastfeeding
  • Contraindications to any of the imaging procedures:
  • MRI (e.g., presence of metal implants or claustrophobia)
  • EUS (e.g., severe anal stenosis or intolerance to procedure)
  • Anesthesia required for EUA (e.g., significant cardiopulmonary disease)
  • Prior surgery or seton placement at the index fistula site
  • Incomplete or failed imaging in any one of the modalities
  • Inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asian Institute of Gastroenterology

Hyderabad, Telanagana, 500082, India

RECRUITING

MeSH Terms

Conditions

Crohn DiseaseFistula

Interventions

Magnetic Resonance ImagingEndosonography

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonography

Central Study Contacts

Partha Pal, MD, DNB, MRCP (UK), FASGE

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Although outcome assessors for each imaging modality (TPUS, MRI, EUS, EUA) are independently blinded to the findings of other modalities, the study design is a single-arm diagnostic comparison. Therefore, "No Masking" is selected to comply with ClinicalTrials.gov system requirements.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: All participants will undergo four diagnostic imaging procedures-transperineal ultrasound (TPUS), magnetic resonance imaging (MRI), endoscopic ultrasound (EUS), and examination under anesthesia (EUA)-in a predefined sequence. Each participant receives the same set of assessments, allowing within-subject comparisons across modalities. The goal is to evaluate the diagnostic accuracy and clinical impact of each imaging test for perianal fistulas in Crohn's disease and cryptogenic cases.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2025

First Posted

August 31, 2026

Study Start

July 25, 2025

Primary Completion (Estimated)

April 15, 2027

Study Completion (Estimated)

April 30, 2027

Last Updated

August 31, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared publicly due to the nature of the diagnostic imaging data, which includes potentially identifiable health information. Data will be stored securely and used only by the study team for the purpose of predefined analyses. Any future data sharing will require additional ethical approval and participant consent.

Locations